Volume 10,Issue 7
Objective: To explore the clinical value of autologous skull transplantation in the treatment of skull defects. Methods: Sixty-six patients who underwent skull defect reconstruction treatment in our hospital from January 2022 to March 2024 were selected and divided into an autologous skull transplantation group (n=31) and an artificial bone transplantation material group (n=35) based on different bone transplantation materials. The two groups of patients were followed up for 12 months to observe the bone healing and the incidence of postoperative complications. Results: After 9 months of treatment, the bone healing performance of the autologous skull transplantation group was better than that of the artificial bone transplantation material group (P < 0.05). By the end of the last follow-up, the incidence of bony postoperative complications in the autologous skull transplantation group was lower than that in the artificial bone transplantation material group (P < 0.05). Conclusion: Autologous skull repair for skull defects has good biocompatibility, can promote bone healing, and reduce the incidence of postoperative complications.